MedTrace Logo

A Study to Assess the Acceptability and Usability of a New Device for Intradermal Vaccination

NCT01963338 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2016-03-17

No results posted yet for this study

Summary

The aim of this study was to assess the acceptability and usability of a newly developed intradermal device in healthy adults

Conditions

  • Pain
  • Vaccination Adverse Event

Interventions

DRUG

Intramuscular injection in the upper arm (0,5cc NaCl 0,9%)

This injection is conducted by needle and syringe in the upper arm (deltoid region).

DEVICE

Intradermal injection in the forearm (0,1cc NaCl 0,9%)

This injection is conducted by the newly developed device.

DEVICE

Intradermal injection in the upper arm (0,1cc NaCl 0,9%)

This injection is conducted by the newly developed device in the upper arm (deltoid region).

Sponsors & Collaborators

  • Pierre Van Damme

    lead OTHER

Principal Investigators

  • Pierre Van Damme, Prof. · Universiteit Antwerpen

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01963338 on ClinicalTrials.gov